Sethuraman Natarajan

President, Research &Develop. | Chief Scientific Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+14.0%

Avg 12M Return

+51.1%

Sethuraman Natarajan is a President, Research &Develop. at Entrada Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.

Estimated insider holdings value: $1.4M based on current market prices.

Holdings by Company

TRDAMay 4, 2026

Current Shares216.3K

Value$1.40M

Net Activity-110,025

Bought: 0Sold: 110.0K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 4, 2026	TRDA Entrada Therapeutics, Inc.	President, Research &Develop.	Sell	25,907	$15.39	$398,809.77	-10.7%	-	-
Dec 3, 2024	TRDA Entrada Therapeutics, Inc.	President, Research &Develop.	Sell	15,891	$20.18	$320,619.70	-3.3%	-43.8%	-50.1%
Nov 13, 2024	TRDA Entrada Therapeutics, Inc.	President, Research &Develop.	Sell	4,109	$20.03	$82,299.94	-1.3%	-38.7%	-56.0%
Nov 6, 2024	TRDA Entrada Therapeutics, Inc.	President, Research &Develop.	Sell	18,219	$18.62	$339,280.66	-2.6%	-27.3%	-62.8%
Oct 16, 2024	TRDA Entrada Therapeutics, Inc.	President, Research &Develop.	Sell	600	$18.00	$10,800.00	-0.3%	-29.3%	-65.0%
Sep 9, 2024	TRDA Entrada Therapeutics, Inc.	Chief Scientific Officer	Sell	3,242	$15.12	$49,003.59	-0.9%	+43.2%	-65.8%
Jul 15, 2024	TRDA Entrada Therapeutics, Inc.	Chief Scientific Officer	Sell	1,238	$18.00	$22,284.00	-0.3%	-0.2%	-64.3%
May 20, 2024	TRDA Entrada Therapeutics, Inc.	Chief Scientific Officer	Sell	18,980	$15.16	$287,694.89	-3.1%	+7.8%	-46.2%
Jul 11, 2023	TRDA Entrada Therapeutics, Inc.	Chief Scientific Officer	Sell	17,878	$18.03	$322,389.28	-5.3%	-20.9%	-12.6%
Apr 17, 2023	TRDA Entrada Therapeutics, Inc.	Chief Scientific Officer	Sell	3,961	$18.00	$71,315.82	-2.3%	-7.9%	-29.4%